Severin Schwan has been a difference maker in the business of targeted cancer drugs and understanding the role diagnostics play in matching the right patients with the right treatments. While not all pharma chiefs are willing to pump as much money as Roche into diagnostics and gene sequencing platforms, many of them have been pushing their own companies to follow the lead of targeted drugs such as...